The Potential of Neoagaro-Oligosaccharides as a Treatment of Type II Diabetes in Mice

Marine Drugs - Switzerland
doi 10.3390/md17100541
Full Text
Abstract

Available in full text

Categories
Drug Discovery
Date
Authors

Unknown

Publisher

MDPI AG

Related search

Bromocriptine as a Potential Glucose-Lowering Agent for the Treatment of Prolactinoma With Type 2 Diabetes

Internal Medicine
Internal MedicineMedicine
2019English

A Access in Treatment of Type Ii Diabetes Using Combinational Herbal Compounds

International Journal of Innovative Technology and Exploring Engineering
Mechanics of MaterialsElectronic EngineeringCivilStructural EngineeringElectricalComputer Science
2019English

Potential of Liraglutide in the Treatment of Patients With Type 2 Diabetes

Vascular Health and Risk Management
2009English

Clinical Potential of Treatment With Semaglutide in Type 2 Diabetes Patients

Drugs in Context
Molecular MedicinePharmacology
2019English

Honey as a Sole Treatment of Type 2 Diabetes Mellitus

Endocrinology & Metabolic Syndrome
2016English

Lixisenatide: Evidence for Its Potential Use in the Treatment of Type 2 Diabetes

Core Evidence
MedicineReviewsReferencesPharmacology
2011English

Identification of Potential Type II Diabetes in a Chinese Population With a Sensitive Decision Tree Approach

Journal of Diabetes Research
EndocrinologyMetabolismDiabetes
2019English

Emergence of TCF7L2 as a Most Promising Gene in Predisposition of Diabetes Type II

International Journal of Human Genetics
Genetics
2008English

The Potential of VipAlbumin® To Chronic Inflammation in Type 2 Diabetes Mellitus Balb/C Mice Model

American Journal of Immunology
AllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy